Publications
24
Citations
1,203
Est. group size
~17
Recurring co-author estimate
Active years
21
Publishing since 2004
Michelle H. Tan's research spans cell biology and hematology topics, including studies of cell death signaling pathways (autophagy), energy-sensing proteins (AMP-activated protein kinase), and blood disorders such as immune thrombocytopenia. Her publication record reflects work connecting molecular mechanisms of cell signaling to clinical or disease-relevant contexts. This is a broad mix of basic cell biology and translational medical research.
Publication output has been relatively steady but modest over the last decade, with small fluctuations year to year and no clear long-term growth or decline.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Eltrombopag: More Than Just a Thrombopoietin Receptor Agonist (TPO-RA) in Immune Thrombocytopenia (ITP)
Blood · 2019
- ATG5 Promotes Death Signaling in Response to the Cyclic Depsipeptides Coibamide A and Apratoxin A
Marine Drugs · 2018
- Deconvoluting AMP-activated protein kinase (AMPK) adenine nucleotide binding and sensing
Journal of Biological Chemistry · 2017
- Bone×5
- Journal of Dental Research×3
- Journal of Periodontology×2
- Brain Behavior and Immunity×1
- Journal of Biological Chemistry×1
- Brian L. Foster
Medicine · The Ohio State University
- M.B. Chavez
Medicine · The Ohio State University
- Fatma F. Mohamed
Medicine · The Ohio State University
- Anne George
Medicine · The Ohio State University
- John D. Bartlett
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile